Industry News
Medical Device Industry News
Sleep Apnea Devices Market Forecast Report and Company Analysis 2025-2033 Carefusion, Somnomed, ResMed, Koninklijke Philips, Compumedics, Nihon Kohden, Natus Medical, and Teleflex
The "Sleep Apnea Devices Market Forecast Report by Types, Therapeutic Devices, Diagnostic Devices, End User, Country and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering.
Triangle Rallies to Fund Lifesaving Research and Patient Care Services at Susan G. Komen® Race for the Cure
Jenn Briand, Executive Director at Susan G. Komen. “Providing critical support to those facing breast cancer is at the heart of our mission and ensures everyone has the same chance of survival, but we can’t
U.S. FDA Grants Paige Breakthrough Device Designation for AI Application that Detects Cancer Across Different Anatomic Sites
Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types.
Solace Raises $60M Series B | To Establish Healthcare Advocacy as New Standard of Care
This raise reflects accelerating market conviction that healthcare advocacy is a critical standard of care that drives better outcomes, lowers costs, and enhances patient experiences notes Solace.
Experienced Medtech Executive Raymond W Cohen Appointed Chairman of Nalu Medical’s Board of Directors
Raymond W Cohen is an accredited public company director with more than 40 years of experience in the life sciences industry.
Dr. Vivien Bonazzi Named Chief Data Officer at Inari
Prior to joining Inari, Dr. Vivien Bonazzi served as chief biomedical data scientist and managing director at Deloitte Consulting LLP.
Pillar Biosciences Receives CMS Coverage for FDA Approved oncoReveal® CDx Pan-Cancer Solid tumor IVD Kit
oncoReveal® CDx is a NGS based IVD kit that uses Pillar's proprietary SLIMamp (Stem-Loop Inhibition-Mediated amplification) technology for detection of single nucleotide variants (SNVs), insertions and deletions in 22 genes using DNA isolated from formalin-fixed
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network
Through this collaboration, Onsite Women'sHealth will offer MammoScreen across its 150+ locations to elevate patient care, while empowering radiologists with AI-driven insights to support earlier and more accurate cancer detection.
Dräger Reports US availability of next- generation Polaris® OR lights
Innovations in surgical light technology can help ORs advance surgical precision, simplify workflow, and increase patient safety notes Dräger.
SimX and Elevate Healthcare Unite to Launch Next-Gen Healthcare Simulation Solutions
SimX, the leader in virtual reality (VR) healthcare training, and Elevate Healthcare, formerly CAE Healthcare, a global leader in simulation-based education, are proud to announce a strategic collaboration aimed at transforming the landscape of medical
The Science Behind Cellura: Revolutionizing Anti-Aging Skincare
ORDER CELLURA HERE WITH 40% OFF DISCOUNT Let’s be honest: aging is something we all face, but how we experience it can be drastically different depending on the choices we make. For years, I searched
InfuSystem Announces CEO Transition | Carrie Lachance to Become CEO Effective May 19, 2025
“Carrie Lachance has been at the center of InfuSystem’s succession plan for the past several years, and she is the ideal person to succeed Rich DiIorio having spent the last decade plus working her way
restor3d Receives FDA Clearance for iTotal IdentityTM CR 3DP Porous Fully Personalized Total Knee Replacement System
This milestone marks a significant achievement in expanding restor3d’s knee replacement technology since the acquisition of Conformis, introducing the first cementless offering to the patient-specific implant portfolio. The company plans a limited market release in
ITM Appoints Dr. Celine Wilke Chief Medical Officer
“Celine brings a wealth of experience in advancing radiopharmaceutical precision oncology treatments from early development through to regulatory approval. As she steps into the leadership of our medical team, her expertise will be instrumental in
Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.
Olga Uspenskaya-Cadoz Appointed Chief Medical Officer of VectorY Therapeutics
Dr. Uspenskaya-Cadoz brings two decades of experience in neurology, gene therapy, and clinical development, enhancing VectorY’s leadership in developing transformative treatments for neurodegenerative conditions.
SHL Medical Expands with $220M US Manufacturing Facility
SHL Medical is significantly increasing its production capacity to meet growing demand in North America while strengthening supply chain resilience.
Plant Biotechnology Market worth $76.79 billion by 2030
The plant biotechnology market is estimated at USD 51.73 billion in 2025 and is projected to reach USD 76.79 billion by 2030, at a CAGR of 8.2% from 2025 to 2030, according to a report
Franco Cavaleri Challenges Conventional Alzheimer’s Theories in Groundbreaking Study
This research, featured in Frontiers in Neuroscience, proposes a paradigm shift in understanding the function of Aβ, suggesting they may serve a protective role against metal toxicity in the brain rather than being primary culprits
NEC Corporation Has Developed Technologies that Enable a Secure Workflow for Personalized Cancer Vaccines & Has Proven their Capabilities
This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies